OSLO, March 26 (Reuters) - Norway will delay a decision over
the use of AstraZeneca's COVID-19 vaccine, authorities
said on Friday, whose rollout has been suspended after several
younger inoculated people were hospitalised, some of whom later
died.
A decision is now expected by April 15, the Norwegian
Institute of Public Health said.
(Reporting by Gwladys Fouche, editing by Terje Solsvik)